investor harm

Driven Brands faces securities fraud class action over unreconciled cash balance causing overstated revenues and understated expenses in 2023-2024.

Class action lawsuit filed against $IBRX alleging securities fraud over false statements regarding Anktiva capabilities. Investors who purchased shares January-March 2026 may be eligible.

Class action lawsuit filed against POET Technologies alleging securities fraud, misrepresentation of tax status, and officer's NDA violation affecting April 2026 investors.

Class action lawsuit filed against Aldeyra Therapeutics alleging false statements regarding reproxalap clinical trial results. Investors from Nov 2023-Mar 2026 may be eligible.

Class action filed against $EOSE alleging securities fraud over undisclosed production delays, quality control failures, and inaccurate guidance from November 2025 to February 2026.

Class action lawsuit filed against $MNDY alleging materially false statements about revenue outlook and sales cycles from September 2025 to February 2026.

Class action lawsuit filed against Alight ($ALIT) alleging executives made false statements about CEO transition, capital returns, and revenue growth between November 2024 and February 2026.

Class action filed against Regencell Bioscience for allegedly false statements on operations and market manipulation vulnerabilities affecting investors during October 2024-October 2025 period.

Class action lawsuit filed against Boston Scientific alleging materially false statements about U.S. electrophysiology segment growth. Investors who purchased BSX shares July 2025-February 2026 eligible.

Trip.com faces class action alleging inadequate disclosure of monopoly-related regulatory risks. Investors harmed from April 2024 to January 2026 can join the lawsuit by May 11, 2026.

Class action lawsuit filed against $COTY alleging executives made false statements about growth prospects during November 2025-February 2026 period.

Class action lawsuit filed against New Era Energy & Digital ($NUAI) alleging materially false statements about Texas data centers project and New Mexico oil and gas operations.

Class action lawsuit filed against $PINS alleges false statements on ad revenues, tariff impacts, and failure to disclose restructuring plans.

Super Micro Computer faces class action lawsuit alleging concealment of Chinese sales violating export controls and compliance weaknesses. Shareholders eligible to join through May 26, 2026 deadline.

Class action lawsuit alleges Driven Brands made false statements about financial condition, internal controls between May 2023 and February 2026.

Class action lawsuit filed against Medpace Holdings alleging executives made false statements about book-to-bill ratio from April 2025 to February 2026.

Class action lawsuit filed against $UHG alleging false statements and nondisclosure regarding controlling shareholder's plan to force company sale and devalue stock.

Lawsuit alleges $GLBT misled investors about Latin American operations, citing failed pivot, client losses, and wage freezes despite leadership claims.

Class action lawsuit filed against $NKTR alleging materially false statements regarding REZOLVE-AA trial enrollment protocols, claiming significant negative impact on trial integrity and results.

Class action lawsuit filed against $SLNO alleging failure to disclose fluid retention safety concerns in DCCR drug trials, harming investors who bought shares March-November 2025.